“Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study” (2018) SKIN The Journal of Cutaneous Medicine, 2, p. S86. doi:10.25251/skin.2.supp.87.